Correlation between oculometric measures, disease severity, and clinical assessment in patients with Parkinson’s disease
Objective: To evaluate the correlation between oculometric measures (OMs), disease severity, and clinical assessment in a cohort of patients with Parkinson’s disease (PD). Background: Oculometric…Is it safe to switch from constant voltage to constant current with a mixed Internal Pulse Generator in deep brain stimulation
Objective: Deep brain stimulation (DBS) is an efficient treatment modality for Parkinson's Disease (PD), essential tremor and dystonia. Differing from the Constant Voltage-(CV)-DBS devices, Constant…Delta(0.5-2Hz) Spectral Power reduction in the frontal region in NREM Sleep are Associated with dyskinesia in Parkinson’s Disease
Objective: Our study aimed to establish the objective physiological indicators assessed by polysomnography(PSG) that are associated with dyskinesia in PD patients.Our study aimed to establish…GBA haplotypes and age at onset of Parkinson’s disease in the Asian population
Objective: To explore the involvement of GBA haplotypes in age at onset of Parkinson's disease in the Asian population. Background: GBA is an important risk…Sleep seasonality in alpha-synucleinopathies: a comparative study with non-neurological sleep disorder patients
Objective: To assess month of the year related changes in polysomnography (PSG) data in patients with alpha-synucleinopathies. Background: Season of the year related changes in…NLX-112 has favorable safety and tolerability and displays efficacy against levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD)
Objective: To assess the safety, tolerability and preliminary efficacy of NLX-112 (a.k.a. befiradol) in patients with moderate to severe LID in PD: a randomized, double-blind,…Alzheimer’s Disease Co-pathology and its Influence on Biofluid Biomarkers in Autopsied Subjects from the PPMI Study
Objective: To examine the relationship between biofluid biomarkers and post-mortem pathological findings in autopsied subjects from the Parkinson’s Progression Marker Initiative (PPMI). Background: The PPMI…Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism
Objective: To analysis of glial neurotrophic factor content in blood serum of patients with PD and VP. Background: Parkinson's disease (PD) and vascular parkinsonism (VP)…Does fatigue in Parkinson’s disease impact one’s physical function in daily live?
Objective: To investigate fatigue at baseline and 3.5 years later and its association with balance and gait over time. Background: In Parkinson’s disease (PD), fatigue…Identifying delirium in Parkinson’s: evaluation of existing tools and measures
Objective: To evaluate the diagnostic accuracy of tools to identify delirium in inpatients with Parkinson’s disease (PD). Background: Delirium is a serious acute state of…
- « Previous Page
- 1
- …
- 228
- 229
- 230
- 231
- 232
- …
- 436
- Next Page »